Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction
Our study highlights the potential of plasma Ckmt2 as a biomarker for assessing reperfusion injury and its impact on cardiac function and morphology in the acute phase of MI.
Authors
- Norbert Gerdes (ORCID: https://orcid.org/0000-0002-4546-7208)
- Malte Kelm (ORCID: https://orcid.org/0000-0003-0060-1052)
- Susanne Pfeiler (ORCID: https://orcid.org/0000-0002-8591-6186)
- Christian Jung (ORCID: https://orcid.org/0000-0001-8325-250X)
- Yvonne Reinders (ORCID: https://orcid.org/0000-0003-1441-6149)
- Albert Sickmann
- Amin Polzin (ORCID: https://orcid.org/0000-0002-5891-9672)
- Lisa Dannenberg (ORCID: https://orcid.org/0000-0002-1627-5274)
- Maike Barcik
- Madlen Kaldirim
- Daniel Oehler (ORCID: https://orcid.org/0000-0002-0435-4119)
- Maria Grandoch (ORCID: https://orcid.org/0000-0002-4382-1947)
- Marcel Benkhoff (ORCID: https://orcid.org/0000-0001-6107-7421)
- Alexander Lang (ORCID: https://orcid.org/0000-0001-6006-7109)
- Khatereh Shahrjerdi
Institutions
- University of Aberdeen (GB)
- Düsseldorf University Hospital (DE)
- Leibniz Institute for Analytical Sciences - ISAS (DE)
- Heinrich Heine University Düsseldorf (DE)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-10-16
- DOI
- https://doi.org/10.3390/biomedicines12102368
- Citations
- 2
- Primary Topic
- Cardiac Ischemia and Reperfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.85